Table 1. Baseline demographics of JBR.10 patient subgroups with or without overexpression of ACTN4.
Total number N = 133) | ACTN4 (+)(N = 25) | ACTN4 (−) (N =108) | P-value | |||
---|---|---|---|---|---|---|
Average age (yr), +/− SD | 63.18 | 7.98 | 60.26 | 9.22 | 0.12* | |
Sex | ||||||
Male | 91 | 20 | 71 | 0.23** | ||
Female | 42 | 5 | 37 | |||
Stage | ||||||
IB | 73 | 16 | 57 | 0.38** | ||
II | 60 | 9 | 51 | |||
Pathological subtype | ||||||
SCCa | 52 | 15 | 37 | 0.018** | ||
Non-SCC | 81 | 10 | 71 | |||
Treatment | ||||||
ADJb | 71 | 15 | 56 | 0.51** | ||
OBSc | 62 | 10 | 52 |
P-values, Student's t-test
P-values, Fisher's exact test
SCC: squamouse cell carcinoma
ADJ; adjuvant chemotherapy
OBS; observation